Please login to the form below

Not currently logged in
Email:
Password:

SEC

This page shows the latest SEC news and features for those working in and with pharma, biotech and healthcare.

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

Lilly ends $1.4bn deal with immuno-oncology biotech NextCure

NextCure did not reveal why Lilly decided to terminate the agreement, saying in a brief US Securities and Exchange Commission (SEC) filing:. ... Shares in the biotech fell shortly after the SEC filing was released – the company is also due to present

Latest news

More from news
Approximately 2 fully matching, plus 63 partially matching documents found.

Latest Intelligence

  • Creating a successful global compliance programme Creating a successful global compliance programme

    The importance of effective compliance programmes was highlighted in the DOJ and SEC’s Resource Guide to the US Foreign Corrupt Practices Act, which describes in detail the hallmarks of a

  • Deal Watch January 2018

    However, in the meantime the US Securities and Exchange Commission (SEC) has issued a lawsuit against some traders for insider trading based on a series of suspicious transactions that made about

  • US health reforms US health reforms

    In March, the Securities and Exchange Commission (SEC) only narrowly blocked this move.

  • Deal Watch - May 2017 Deal Watch - May 2017

    A good example is Abbott’s acquisition of the diagnostics company Alere signed in February 2016.  Two months later Abbott asked Alere to cancel the transaction because of a SEC inquiry ... into accounting issues at Alere and offered $30m to $50m

  • On the road with the millennial HCP On the road with the millennial HCP

    Yeah I'll put Andy on. Just hang on a sec, he's just sorting our next lift.”.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • SALES ACCELERANT

    We help companies to engage prim/sec care healthcare professionals more efficiently and effectively to drive sales growth.

  • SEC Pharma

    Analysis, SEC can assist wherever you are looking to hire or work throughout the UK and Europe.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics